Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
April 17, 2024 07:49 ET
|
Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery...
[Latest] Global Pet Cancer Therapeutics Market Size/Share Worth USD 1,162.4 Million by 2033 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 08, 2024 13:30 ET
|
Custom Market Insights
Austin, TX, USA, April 08, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pet Cancer Therapeutics Market Size, Trends and Insights By Therapy...
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
March 25, 2024 07:48 ET
|
MetasTx LLC
Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
March 21, 2024 07:58 ET
|
CAMP4 Therapeutics
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle D
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
March 14, 2024 05:00 ET
|
S. M. Discovery Group (SMDG)
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
February 29, 2024 09:54 ET
|
PRISM MarketView
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
Digital Therapeutics Market Size to Reach US$24.5 Billion by 2030, Forecasts Fairfield Market Research in a New Report
February 27, 2024 07:32 ET
|
Fairfield Consultancy Services OPC Pvt Ltd
London, Feb. 27, 2024 (GLOBE NEWSWIRE) -- As indicated by a newly published report by Fairfield Market Research, the global market for digital therapeutics is poised to witness staggering growth,...
Global Ophthalmic Drugs Market Size is Estimated to Reach USD 62.55 billion by 2030, Growing at a CAGR of 7.4%: Straits Research
February 21, 2024 10:20 ET
|
Straits Research
New York, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Anti-infectives in a product designed specifically to be injected into or applied to the eye or eyes are known as ophthalmic...
Pneumonia Therapeutics Market Forecasted to Grow at a CAGR of 7.3% by 2031, Reaching a Total Worth of USD 5.7 billion | Transparency Market Research, Inc.
February 19, 2024 05:05 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The pneumonia therapeutics market was valued at US$ 3.0 billion in 2022. A CAGR of 7.3% is...